Drug
Dalteparin clinical trials
Also written Fragmin.
- studies test it
- 52
- open now
- 5
- in phase 3
- 19
- first study started
- 1998
Keep track of what changes. Save the Dalteparin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
52 studies that test it; most in 2002 (6)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2000 | 3 |
| 2002 | 6 |
| 2003 | 5 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 15
- Phase 3
- 19
- Phase 4
- 16
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 44
Pfizer (8) · Ottawa Hospital Research Institute (4) · M.D. Anderson Cancer Center (3) · London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's (2) · Duke University (2) · University of Oklahoma (2) · Ontario Clinical Oncology Group (OCOG) (2) · University of Southern California (2)
Often tested with
Tested in the same studies.
Enoxaparin (7) · Tinzaparin (7) · Apixaban (5) · Rivaroxaban (3) · Dabigatran (2) · Warfarin (2) · Fondaparinux (2) · Gemcitabine (2)
Studies
Open first, then newest update. How each study uses Dalteparin is read from its arms, and is right about nine times in ten.
Testing it · 52
- Thromboprophylaxis in Lower Limb ImmobilisationRecruitingPhase 3Queen Mary University of LondonNCT06370273Written as Dalteparin Injectable Solution
- THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingPhase 4Imperial College LondonNCT05735639Written as Dalteparin Sodium
- STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated ThrombosisRecruitingPhase 4Tzu-Fei WangNCT05255003Written as Dalteparin
- Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic SurgeryRecruitingPhase 4Helsinki University Central HospitalNCT05245877Written as enoxaparin/tinzaparin/dalteparin
- PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)RecruitingPhase 3Sunnybrook Health Sciences CentreNCT03559114Written as Dalteparin
- Causes and Prevention of Thromboembolic Disease in Nephrotic SyndromeCompletedPhase 1/2University of AarhusNCT04850378Written as Dalteparin
- Australasian COVID-19 Trial (ASCOT) ADAptive Platform TrialActive, not recruitingPhase 3University of MelbourneNCT04483960Written as (Arm Closed) Dalteparin
- Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With CancerCompletedPhase 4PfizerNCT00942968Written as dalteparin
- WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous ThromboembolismTerminatedPhase 2Ottawa Hospital Research InstituteNCT03297359Written as Dalteparin
- Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerCompletedNot applicableAlliance Foundation Trials, LLC.NCT02744092Written as Dalteparin
- Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma MultiformeCompletedPhase 2Eastern Cooperative Oncology GroupNCT00028678Written as dalteparin
- Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by SurgeryCompletedPhase 1Roswell Park Cancer InstituteNCT01061411Written as Dalteparin
- Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in PregnancyCompletedPhase 4Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT01828697Written as Low dose dalteparin
- Dalteparin in Preventing DVT in Participants With CancerCompletedNot applicableM.D. Anderson Cancer CenterNCT00525057Written as Dalteparin
- Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous ThromboembolismCompletedPhase 3Academic and Community Cancer Research UnitedNCT02585713Written as Dalteparin
- Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a CatheterCompletedPhase 3Jonsson Comprehensive Cancer CenterNCT00006083Written as Fragmin
- A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis PatientsCompletedPhase 4London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph'sNCT02607111Written as Dalteparin
- Fragmin for the Treatment of Acute VTE in Pediatric Cancer PatientsCompletedPhase 2PfizerNCT00952380Written as dalteparin
- The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following TraumaCompletedNot applicableDenver Health and Hospital AuthorityNCT01050153Written as Dalteparin sodium
- Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic PatientsCompletedPhase 2/3PfizerNCT00662831Written as Fragmin/ Dalteparin Sodium
See all 52 studies that test Dalteparin →
Given in every arm · 1 — Dalteparin is usual care beside what is tested
As the comparator · 8 — what is tested is compared with Dalteparin
- Prolonged Hypercoagulability Following Major Liver Resection for MalignancyNot yet recruitingPhase 3Western University, CanadaNCT06153394Written as Fragmin (dalteparin)
- A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTETerminatedPhase 3Anthos Therapeutics, Inc.NCT05171075Written as Dalteparin
- Apixaban for the Treatment of Venous Thromboembolism in Patients With CancerCompletedPhase 3Fadoi Foundation, ItalyNCT03045406Written as Dalteparin
- A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee ReplacementStatus unknownPhase 2PharmaDiall Ltd.NCT05189002Written as Fragmin
- PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.Status unknownPhase 3London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph'sNCT00432796Written as Dalteparin
- A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismStatus unknownPhase 2Asan Medical CenterNCT03139487Written as Dalteparin
- Cancer Venous Thromboembolism (VTE)CompletedPhase 3Daiichi SankyoNCT02073682Written as Dalteparin
- Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO PilotCompletedPhase 2University of ManitobaNCT01648036Written as Dalteparin
Codes
What other systems call Dalteparin · ClinicalTrials.gg INT008624
- MeSH (NLM) D017985DalteparinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) S79O08V79FDALTEPARINConfirmed FDA, NLM, Wikidata
- RxNorm 67109Confirmed FDA, Wikidata
- Wikidata Q1851701dalteparinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1453DalteparinOne source FDA
- DrugBank DB06779One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017985 | Dalteparin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | S79O08V79F | DALTEPARIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 67109 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1851701 | dalteparin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1453 | Dalteparin | One source FDA |
| DrugBank | DB06779 | — | One source Wikidata |
Also registered as dalteparin sodium (UNII 12M44VTJ7B · RxNorm 82137).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.